A Long-term Safety Study of Infliximab (Remicade)

CompletedOBSERVATIONAL
Enrollment

2,971

Participants

Timeline

Start Date

February 28, 2002

Primary Completion Date

March 31, 2012

Study Completion Date

March 31, 2012

Conditions
Arthritis, RheumatoidCrohn DiseasePsoriasis
Interventions
DRUG

Infliximab (Remicade)

This is an non-interventional study. Participants took the study product as part of their medical routine.

Trial Locations (205)

Unknown

Birmingham

Huntsville

Montgomery

Paradise Valley

Phoenix

Tucson

Little Rock

Anaheim

Fresno

Irvine

Los Angeles

Madera

Orange

Pasadena

Rancho Mirage

San Diego

Santa Monica

Stanford

Torrance

Denver

Hamden

Hartford

New Haven

Waterbury

Aventura

Largo

Ocala

Orlando

Palm Harbor

Sarasota

Tampa

Alpharetta

Atlanta

Marietta

Coeur d'Alene

Chicago

Evanston

Gurnee

Maywood

Normal

Rockford

Springfield

Indianapolis

Iowa City

Overland Park

Wichita

Louisville

Portland

Baltimore

Greenbelt

Wheaton

Andover

Boston

Worcester

Ann Arbor

Detroti

East Lansing

Grand Rapids

Edina

Fridley

Jackson

St Louis

Lincoln

Reno

Voorhees Township

Manhasset

New York

Rochester

Charlotte

Durham

Raleigh

Wilmington

Winston-Salem

Akron

Cincinnati

Cleveland

Columbus

Oklahoma City

Lake Oswego

Portland

Bethlehem

Lancaster

Norristown

Philadelphia Pennsylvan

West Reading

Willow Grove

North Charleston

Goodlettsville

Nashville

Dallas

Houston

Lubbock

San Antonio

Burlington

Salem

Bellevue

Kirkland

Seattle

Spokane

Milwaukee

Buenos Aires

Córdoba

Cp

Rosario

San Miguel de Tucumán

Graz

Innsbruck

Vienna

Brussels

Diepenbeek

Edegem

Genk

Ghent

Leuven

Liège

Calgary

Edmonton

Richmond

Vancouver

Winnipeg

Moncton

St. John's

Halifax

Hamilton

Kitchener

London

Markham

Newmarket

North Bay

Ottawa

Toronto

Waterloo

Montreal

Québec

Sainte-Foy

Sherbrooke

Ste-Foy

Halifax

Hamilton Ontario

Montreal

Saskatoon

Aarhus

Hellerup

Hvidovre

København NV

Odense

Helsinki

Hus

Jyväskylä

Pikonlinna

Créteil

Montpellier

Nantes

Nice

Paris

Pierre-Bénite

Poitiers

Berlin

Bochum

Cologne

Dresden

Erlangen

Frankfurt

Hamburg

Leipzig

Mainz

Münster

Oldenburg

Würzburg

Wÿrzburg

Budapest

Debrecen

Dublin

Haifa

Tel Aviv

Amsterdam-Zuidoost

Maastricht

Rotterdam

Utrecht

Oslo

Bialystok

Lublin

Szczecin

Warsaw

Wroclaw

Włoszczowa

Barcelona

Buenos Aires

Córdoba

Federal

Madrid

Gothenburg

Geneva

Zurich

Bath

Birmingham

Cambridge

Cannock

Leeds

Liverpool

London

Manchester

Newcastle upon Tyne

Norwich

Oxford

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Centocor BV

INDUSTRY

lead

Centocor, Inc.

INDUSTRY